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Because it controls the majority of polyketide
stereocenters, the ketoreductase (KR) is a cen-
tral target in engineering polyketide synthases
(PKSs). To elucidate the mechanisms of stereo-
control, the structure of KR from the first mod-
ule of the tylosin PKS was determined. A com-
parison with a recently solved erythromycin
KR that operates on the same substrate
explains why their products have opposite a-
substituent chiralities. The structure reveals
how polyketides are guided into the active site
by key residues in different KR types. There
are four types of reductase-competent KRs,
each capable of fixing a unique combination
of a-substituent and b-hydroxyl group chiral-
ities, as well as two types of reductase-incom-
petent KRs that control a-substituent chirality
alone. A protocol to assign how a module will
enforce substituent chirality based on its se-
quence is presented.
INTRODUCTION
Polyketides are an important class of pharmaceuticals
that are primarily produced by streptomycetes, a type of
soil bacteria [1–5]. The antibiotic tylosin is synthesized
by Streptomyces fradiae using a megasynthase that can
be described as a molecular assembly line [6]. The seven
modules of the tylosin polyketide synthase (PKS) con-
dense one ethylmalonyl, four methylmalonyl, and two ma-
lonyl extender units onto a priming propionyl unit to yield
the 23-carbon macrocycle, tylactone, which is subse-
quently modified through oxidations and glycosylations
into tylosin (Figure 1A).
Within a module, an extender unit is selected by an acyl-
transferase (AT), shuttled by an acyl carrier protein (ACP)
via an 18 A˚ long phosphopantetheinyl arm, and con-
densed to the growing polyketide chain by a ketosynthase
(KS) [4, 7]. Three b-carbon processing enzymes can act on
the b-keto group formed after each condensation: a ketor-
eductase (KR) uses NADPH to stereospecifically reduce it
to a hydroxyl group, a dehydratase (DH) removes the hy-
droxyl group to create a double bond, and an enoylreduc-898 Chemistry & Biology 14, 898–908, August 2007 ª2007 Eltase (ER) uses NADPH to stereospecifically reduce the
double bond. A methylene functionality is produced by
a module containing each of these enzyme activities in
a reaction sequence that parallels that of the related ani-
malian fatty acid synthase (FAS) [8, 9]. To create a more
functionalized ketide unit, enzymes acting on the b-carbon
are either inactive or absent from the module that controls
its addition to the growing polyketide chain. The combina-
tions of the substituents that branch from the acyl chain
and their chiralities make polyketides one of the most
diverse classes of molecules.
Since the discovery of PKSs, it was apparent that AT
controls the identity of the majority of the polyketide sub-
stituents through its selection of extender units larger than
a malonyl group [10]; however, the mechanisms that set
the chiralities of those substituents, as well as any
hydroxyl substituents, are only now being deciphered. Se-
quence motifs, or fingerprints, have been detected within
KRs that are predictive of hydroxyl group stereochemistry:
A-type KRs employ a conserved tryptophan to produce
a hydroxyl group of ‘‘S’’ stereochemistry; B-type KRs em-
ploy an LDD motif to produce a hydroxyl group of ‘‘R’’ ste-
reochemistry (quotation marks are placed around R and S,
as the convention used to label chiral centers in polyketi-
des can deviate from the RS system: when discussing chi-
rality at the b position, the g position is given the lowest pri-
ority after the hydrogen; when discussing chirality at the
a position, the a-substituent is given the lowest priority af-
ter the hydrogen) [11, 12]. The mechanisms used by KRs
to set b-hydroxyl group stereochemistry are currently be-
ing elucidated [13]; however, even the identities of the en-
zymes controlling a-substituent stereochemistry have not
been established [14, 15].
The chirality of the a-substituent (usually a methyl, ethyl,
or methoxy group) has been studied at various stages of
polyketide synthesis (Figure 1B): ATs only select extender
units with an a-substituent of ‘‘S’’ stereochemistry, such
as (2S)-methylmalonyl-CoA [16]. During the condensation
reaction, KSs reverse the a-substituent chirality to yield
a polyketide chain with an a-substituent of ‘‘R’’ stereo-
chemistry [14, 16]. In studies of DEBS1-TE, which con-
tains the first and second modules of the erythromycin
PKS, a triketide lactone product revealed that a deuterium
attached to the a-carbon of (2S)-methylmalonyl-CoA was
not incorporated by the first module, but was incorporated
by the second module. This result indicated that another
reversal of the a-substituent chirality occurs after thesevier Ltd All rights reserved
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(A) Primer and extender units are selected, fused, and reduced in a stereocontrolled manner by the tylosin PKS to yield tylactone, the precursor to the
antibiotic tylosin. TylKR1 sets the stereochemistry at the labeled stereocenters.
(B) Polyketide intermediates during catalysis by the first module of the tylosin PKS. The product of TylKS1 is the ‘‘R’’ diketide. TylKR1 acts on this
diketide epimer, thereby setting the a-substituent chirality of the product. The stereospecific reduction also sets the chirality of the resulting
b-hydroxyl group.condensation reaction in the first module to yield an a-
substituent of ‘‘S’’ stereochemistry.
Four theories have been presented to explain how a-
substituent stereochemistry is set. (1) Some KSs are ca-
pable of catalyzing epimerization after condensation to
yield a mixture of epimers, and a downstream enzyme se-
lects the epimerized polyketide [17]. (2) Some modules al-
low spontaneous epimerization to occur in water, and
a downstream enzyme selects the epimerized polyketide
[17]. (3) KR catalyzes a cryptic epimerization, in which
the polyketide exists in the enol form during hydride at-
tack, and a-substituent chirality is determined by the
side of the enol that the a-carbon acquires a proton [15].
(4) Some KRs have evolved the ability to catalyze epime-
rization before catalyzing the reduction reaction [18].
Recently, KRs isolated from their PKSs have aided in
distinguishing between these possibilities. EryKR1 and
TylKR1 were shown to maintain stereocontrol of the a-
substituent and the b-hydroxyl group during in vitro reac-
tions with polyketide substrates (the nomenclature
describes a domain by its PKS and module of origin)
(Figure 2A) [19]. Both enzymes can reduce a racemic mix-
ture of diketide substrate analogs into the anticipated
products (analogous to their diketide products in their na-
tive PKSs), which differ only in the stereochemistry of thea-
methyl group. A racemic substrate mixture may not seem
representative of the polyketides naturally presented to
KR, as KS may only produce the unepimerized polyketide;
however, KRs need to contend with the spontaneous epi-
merization that occurs at some frequency to unreduced
polyketide intermediates, as with all substituted dicarbonyl
compounds exposed to water [20].
The structure of EryKR1 revealed the active site groove
that polyketides enter from the left side in A-type KRs andChemistry & Biology 14, 89from the right side in B-type KRs, resulting in opposite b-
hydroxyl group chiralities [18]. However, because features
surrounding the EryKR1 active site were not highly or-
dered, the structure did not elucidate how a polyketide
could be differentially guided into the groove. It was also
unclear how KRs are specific for the epimer they reduce.
In order to determine the mechanisms that set a- and b-
substituent chirality, the atomic resolution structure of
the KR active site as it is arranged during catalysis is
required.
TylKR1 was solved to 1.95 A˚ resolution (Figure 2B). It
has the same fold as EryKR1; however, the active site is
more ordered and may represent the conformation adop-
ted during catalysis. Most notably, aFG and the loop that
precedes it, referred to as the ‘‘lid’’ in related short-chain
dehydrogenase/reductase (SDR) enzymes, help form the
substrate binding site [21, 22]. Through modeling the nic-
otinamide portion of NADPH and a diketide substrate into
the active site, the mechanisms by which key residues
control a- and b-substituent chirality are elucidated.
Structural data, sequence alignments, and substituent
chiralities observed in polyketides, analyzed together,
reveal that at least six types of KRs exist. A protocol to
deduce the ketide unit that is added by a module based
on its sequence is presented.
RESULTS
Overall Structure
As with EryKR1, TylKR1 is composed of two subdomains,
each resembling a Rossmann fold (Figure 2B) [18]. The
structural subdomain does not have a dinucleotide binding
site, and its principal role is apparently to stabilize the
catalytic subdomain for catalysis. The catalytic residues8–908, August 2007 ª2007 Elsevier Ltd All rights reserved 899
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(A) Both TylKR1 and EryKR1, separated from their PKSs, maintain stereocontrol of the a and b positions. The enzymes choose opposite epimers for
the reduction reaction. The diketide substrate analog exists as a racemic mixture, as dicarbonyl compounds spontaneously epimerize in water.
(B) A superposition of TylKR1 (blue) and EryKR1 (green) reveals the 7 A˚ shift of the N-terminal end of the lid helix. The order around the active site
indicates that TylKR1 is in the closed, or active, conformation. NADPH is from the EryKR1 structure.cooperate as observed in related SDR enzymes [22]: the
catalytic tyrosine, Y383, and a strictly conserved serine,
S370, position the carbonyl that is to be reduced adjacent
to the reactive NADPH hydrogen (numbering is based on
the first observable residue in the structure; to obtain ac-
tual numbering, add 1961) (Figure 3A). Y383 is activated
into a general acid by a neighboring lysine, K345, to donate
its proton to the carbonyl oxygen after hydride transfer.
Mutation of the catalytic tyrosine to a phenylalanine pre-
vented EryKR6 from catalyzing the reduction reaction [12].
The overall structures of TylKR1 and EryKR1 are quite
similar (1.70 A˚ Ca root-mean-square deviation), but it is
their differences that are informative (Figure 2B). The N-
terminal end of the lid helix is 7 A˚ closer to the active site
than observed in EryKR1 (it was distant from the active
site in one crystal form and unobservable in another; Pro-
tein Data Bank [PDB] ID codes 2FR0 and 2FR1). Residues
from the lid helix make specific interactions with active site
residues: E424 hydrogen bonds with Q380; L426 contacts
L411 and L431; and the G422 carbonyl hydrogen bonds
with N377. The residues of the LDD motif, which lie on
the ‘‘LDD loop,’’ are also more ordered than observed in
the EryKR1 structure (Figure 3A). The first aspartate
caps aF via the catalytic tyrosine amide, while the second
aspartate caps the lid helix. Compared to EryKR1, a con-
served methionine on the loop preceding the lid helix,
M417, is more ordered and closer to where the nicotin-
amide portion of NADPH binds.900 Chemistry & Biology 14, 898–908, August 2007 ª2007 ElseTylKR1 crystallized in the absence of NADPH, enabling
a comparison of its empty binding site with the bound site
of EryKR1. The dinucleotide binding motif (consensus:
TGG[S,T][G,A][G,A,T,V][V,I,L][G,A]), which makes contact
with the adenine ribose and associated phosphoryl
groups in EryKR1, remains well ordered in the absence
of NADPH and is in the same conformation observed in
EryKR1. However, several residues that would have
made contact with the adenine ring (R271 and D299-
E302) have elevated temperature factors.
The Ternary Complex and ACP Docking
The well-ordered, specific interactions of active site resi-
dues with the lid helix and the LDD loop indicate that
TylKR1 is in a closed conformation representative of its
active state during catalysis. To detail how substituent chi-
ralities are set by KR, the nicotinamide portion of NADPH
and the unepimerized diketide substrate were modeled
into the active site (Figure 3B). The nicotinamide half of
NADPH was placed in the orientation observed in the ter-
nary complex of the related tropinone reductase, with the
hydroxyl groups of the nicotinamide ribose hydrogen
bonding to the catalytic tyrosine, Y383, and neighboring
lysine, K345 (PDB ID code 1IPF) [23]. The b-carbonyl of
the diketide substrate was positioned between S370 and
Y383. The polyketide was oriented to enter the active site
groove from the right side, as observed in related enzymes
that operate on phosphopantetheinyl-bound substratesvier Ltd All rights reserved
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(A) The 2Fo  Fc electron density map (1.2 s) reveals the order of key residues in the lid and LDD loop that surround the active site.
(B) NADPH and the diketide substrate are modeled in the active site. L325 guides the polyketide from the right side of the active site groove by making
hydrophobic contact with the terminal portion of the phosphopantetheinyl arm. The b-carbonyl accepts a hydrogen bond from Y383. The a-hydrogen
interacts with the E424 carboxylate. The epimerized diketide might not bind due to a clash between the a-methyl group and the E424 carboxylate.(e.g., FabI; PDB ID code 1BVR) [24]. This places the thio-
ester carbonyl adjacent to the nicotinamide ribose 20-
hydroxyl group and the terminal hydrophobic portion of
the phosphopantetheinyl arm adjacent to L325 from the
LDD motif.
In the ternary complex, TylKR1 makes several favorable
contacts to the a-hydrogen and a-methyl group of the un-
epimerized diketide (Figure 3B). E424 from the lid helix,
positioned by Q380 and the G421 amide, hydrogen bonds
with the partially positive a-hydrogen. The g-methylene
unit of E424 makes a hydrophobic contact with the a-
methyl group. An epimerized diketide would not fit due
to a steric clash between its a-methyl group and the
E424 carboxylate.
ACP must dock to KR in order to swing the polyketide
via the phosphopantetheinyl arm into the KR active site
(Figure 4A). Adjacent to the phosphopantetheinylated ser-
ine of ACP is a conserved hydrophobic residue that is hy-
pothesized to interact with a hydrophobic patch on the KR
surface during docking [25]. Experiments on the related
enzyme FabG suggest this surface is near the C-terminal
end of a4 [26]. Using an FAS ACP as a model (PDB ID
code 2FAE), TylACP1 was docked to TylKR1 while keep-
ing its N terminus in proximity to the TylACP1 C terminus,
as they are joined by 20 residues [27]. From this docking
site, the phosphopantetheinyl arm is in a position to enterChemistry & Biology 14, 8the active site groove from the left side in A-type KRs and
from the right side in B-type KRs.
KR Types
Until now, KRs have only been classified by the b-hydroxyl
group stereochemistry of their products: A-type KRs pro-
duce an ‘‘S’’ hydroxyl group and are characterized
through the absence of an LDD motif and the presence
of a highly conserved tryptophan. B-type KRs produce
an ‘‘R’’ hydroxyl group and are characterized through
the presence of the LDD motif (the leucine is occasionally
replaced by valine or isoleucine; the first aspartate can be
replaced by several residues; the second aspartate is
strictly conserved) (Figure 5).
As KRs maintain stereocontrol when isolated from their
PKSs, it follows that they are responsible for setting both
the resulting b-hydroxyl group and a-substituent stereo-
chemistries. Because several combinations of these
stereochemistries can be achieved, KRs are not fully de-
scribed as either A-type or B-type. From a comparison
of the EryKR1 and TylKR1 structures and sequence align-
ments of KRs that catalyze distinct reactions, previously
undetected fingerprints were identified for six KR types.
It is clear that there are four types of reductase-competent
KRs and two types of reductase-incompetent KRs. There-
fore, the current nomenclature has been expanded by98–908, August 2007 ª2007 Elsevier Ltd All rights reserved 901
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(A) The polyketide chain may be protected from epimerization within ACP until docking to KR. In A- and C2-type KRs, the phosphopantetheinyl arm
slips behind the lid helix into the active site groove to make contact with a conserved tryptophan, so that the polyketide enters the active site from the
left side. In B-type KRs, the phosphopantetheinyl arm encounters the LDD motif, which prevents it from slipping behind the lid helix, so that the poly-
ketide enters the active site from the right side. Only the nicotinamide half of NADPH is shown.
(B) Center: through a combination of binding, epimerization, and reduction events, each KR type controls how a polyketide is processed. Left and
right: catalysis proceeds similarly whether the polyketide enters a KR active site from the left side or from the right side. Epimerization is likely a com-
bination of a catalyzed enolization and an uncatalyzed tautomerization back to the keto form. The catalytic base cannot catalyze enolization of the
epimerized polyketide because the acidic hydrogen is inaccessible. In A2- and C2-type KRs, the base is either a lid helix residue or water; in B2-type
KRs, the base may be the catalytic tyrosine. Reduction occurs through attack of the b-carbon by the NADPH hydride along with the transfer of a proton
from the catalytic tyrosine to the carbonyl oxygen.appending 1 if the a-substituent is not epimerized and 2 if
the a-substituent is epimerized, and by including reduc-
tase-incompetent KRs as ‘‘C-type’’ KRs.
The roles of conserved residues (indicated by bold num-
bering in Figure 5) that enable each KR type to uniquely se-
lect and process a polyketide substrate are described as
follows (Figures 4 and 5).
A1-Type KRs
The unepimerized polyketide enters the active site groove
from the left side, guided by the conserved tryptophan (2).
A glutamine or leucine (3) is in a position to interact with the
unepimerized a-substituent (PhoKR6 employs a serine at
this position to accommodate an ethyl substituent). The
reduction reaction yields an ‘‘S’’ hydroxyl group.
A2-Type KRs
The unepimerized polyketide enters the active site groove
from the left side, guided by the conserved tryptophan (2).
The polyketide is enolized when the acidic a-hydrogen is
abstracted by a base (either a lid helix residue or a water
molecule). An uncatalyzed tautomerization back to the
keto form eventually yields the epimerized polyketide.
The epimerized polyketide is no longer a substrate for
enolization, as its a-hydrogen is inaccessible to the902 Chemistry & Biology 14, 898–908, August 2007 ª2007 Elsebase. A conserved histidine (3) is in position to help select
against the unepimerized polyketide by sterically clashing
with its a-substituent. The reduction yields an ‘‘S’’
hydroxyl group.
B1-Type KRs
The unepimerized polyketide enters the active site groove
from the right side, guided by the leucine of the LDD motif
(1). As in TylKR1, a glutamine (3) can collaborate with lid
helix residues to prevent a spontaneously epimerized pol-
yketide from being reduced. The reduction yields an ‘‘R’’
hydroxyl group.
KRs are usually B1 type when they work in concert with
the other b-carbon processing enzymes DH and ER. This is
readily observed in the avermectin PKS: the catalytic sub-
domains of AveKR7 and AveKR9 are identical in sequence
and are highly likely to produce the same combination of
stereochemistries at the a- and b-carbons. The chiralities
set by AveKR9 are erased through a subsequent dehydra-
tion reaction catalyzed by AveDH9. However, AveKR7 is
observed to produce an ‘‘R’’ a-substituent and an ‘‘R’’
b-hydroxyl group, making it a B1-type KR. Thus, AveKR9
and most KRs that produce a substrate for a DH are
B1-type KRs.vier Ltd All rights reserved
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(A) PKS abbreviations.
(B) An alignment of the TylKR1 and EryKR1 catalytic regions illustrates the architectural differences between KRs. The NADPH and substrate are from
the model of the TylKR1 ternary complex.
(C) Each of the KR types uniquely processes a similar substrate through controlling the chirality of a-substituents and b-hydroxyl groups. Several
regions from representative KRs are aligned to illustrate the fingerprints that can be observed in their sequences. The lid is extremely variable in se-
quence and length, indicating that it may make specific interactions with a bound polyketide. The lid is longer and less variable when an accompa-
nying DH is present. DH, functional; dh, nonfunctional; *, or obscured dinucleotide binding motif.Interestingly, most of the B1-type KRs possess a highly
conserved and slightly longer lid, probably consisting of
two a helices, as in the related SDR enzymes FabG and
FabI [21, 24]. This lid is always present when KR is accom-
panied by a DH. If modular PKSs are descended from
FASs [5], which contain B-type KRs, it is plausible that
all PKS KRs evolved from B-type KRs.
B2-Type KRs
The unepimerized polyketide enters the active site groove
from the right side, guided by the leucine of the LDD motif
(1). The catalytic tyrosine, freed from aF by a conserved
proline (5), may have sufficient flexibility to abstract the
acidic a-hydrogen to enolize the polyketide [18]. A pro-
ductive tautomerization back to the keto form generatesChemistry & Biology 14, 898the epimerized polyketide, which cannot be enolized by
KR because the a-hydrogen is inaccessible to the tyro-
sine. A leucine or a glutamine (3) can collaborate with
the lid helix to help select the epimerized polyketide for re-
duction. In EryKR1, the combination of a leucine at this po-
sition and a valine from the lid helix creates a hydrophobic
pocket for the epimerized a-methyl group. The reduction
yields an ‘‘R’’ hydroxyl group.
C1-Type KRs
These rare, nonfunctional KRs lack the catalytic tyrosine
(4). Because an unepimerized, unreduced ketide unit
can be added by modules completely lacking a KR, there
may be no evolutionary pressure for modules to maintain
these KRs.–908, August 2007 ª2007 Elsevier Ltd All rights reserved 903
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The unepimerized polyketide enters the active site groove
from the left side, guided by the conserved tryptophan (2).
The polyketide is enolized when the acidic a-hydrogen is
abstracted by a base (either a lid helix residue or a water
molecule). An uncatalyzed tautomerization back to the
keto form eventually yields the epimerized polyketide.
The epimerized polyketide is no longer a substrate for
enolization, as its a-hydrogen is inaccessible to the
base. In these KRs, the dinucleotide binding motif is
obscured and the conserved asparagine (6) is typically re-
placed by a smaller residue.
Protocol to Assign Substituent Chirality
From the fingerprints of the six KR types, how a given KR
will enforce substituent chiralities can be deduced from its
sequence (Figure 6). By combining this predictive scheme
in the framework of how a module produces a ketide unit,
a flowchart has been created that can be used to deduce
what addition a module will make to a growing polyketide
chain. This methodology has been developed using every
sequenced PKS that produces a structurally validated
polyketide.
For the protocol to be completely predictive of substit-
uent chirality from modular sequence information alone,
the fingerprints of different types of DHs and ERs need
to be identified. Several PKSs use DHs as epimerases.
Although the conservation of putative DH active site resi-
dues is suggestive of a dehydration-competent enzyme,
sequence information cannot predict whether a DH is an
epimerase, as the associated fingerprint has not yet
been determined. However, if a DH is known not to per-
form the dehydration reaction and its catalytic residues
are conserved, it is likely to be an epimerase. Because
there are so few examples of ERs that reduce a-
substituted polyketides, the fingerprints of ‘‘epimerizing’’
and ‘‘nonepimerizing’’ ERs have yet to be established.
Mutational Analysis of Stereocontrol
The kinetic parameters of EryKR1 and TylKR1 operating
on an unreduced diketide substrate have previously
been measured (Figure 2A) [19]. The b-hydroxyl group of
both products has the same ‘‘R’’ stereochemistry; how-
ever, TylKR1 enforces an ‘‘R’’ stereochemistry on the a-
methyl group, and EryKR1 enforces an ‘‘S’’ stereochemis-
try on the a-methyl group. The ternary model suggests
that Q380 and E424 are important in selecting against
the epimerized diketide in TylKR1. Because the residue
equivalent to Q380 in EryKR1 is a leucine, the Q380L mu-
tant was engineered and assayed for stereocontrol (see
the Supplemental Data available with this article online
for diketide substrate synthesis). The mutant retained
the ability to select the unepimerized diketide, indicating
that E424 from the lid helix is the most important residue
in setting a-substituent chirality. Thus, the E424A mutant
was engineered and assayed for stereocontrol. This mu-
tant was compromised, selecting both epimers for reduc-
tion, although it favored its natural epimer 4:1.904 Chemistry & Biology 14, 898–908, August 2007 ª2007 ElsDISCUSSION
Stereocontrol
TylKR1 was crystallized in the active conformation adop-
ted during catalysis, in which the lid helix and the LDD
motif make specific interactions with active site residues
(Figure 3). Modeling of the nicotinamide portion of NADPH
and the diketide substrate into the active site shows that
the diketide is completely surrounded by NADPH and pro-
tein during catalysis and suggests that the lid helix inter-
acts with bound substrates to ensure a complementary fit.
How B-type KRs use the LDD motif to guide polyketides
into the active site groove is made apparent by consider-
ing how the phosphopantetheinyl arm swings from
a docked ACP into the KR active site groove (Figure 4A).
Because the invariant second aspartate caps the lid helix,
sealing the LDD loop and the lid helix together, the phos-
phopantetheinyl arm is prevented from slipping between
them into the active site groove. To enter the groove, the
arm must swing over the aspartates so that its hydropho-
bic end interacts with the leucine. Polyketides are thus po-
sitioned by B-type KRs to enter the active site from the
right side.
The active sites of A- and C2-type KRs accept polyke-
tides from the left side. These KRs lack the LDD motif
but possess a conserved tryptophan on the left side of
the groove. ACPs probably dock to these KRs very simi-
larly to how they dock to B-type KRs. However, when
the phosphopantetheinyl arm swings toward the active
site, it does not encounter the seal between the lid helix
and the LDD loop that is made in B-type KRs, and can
slip between them. The arm inserts into the KR active
site groove until it contacts the conserved tryptophan.
The tryptophan makes space on the left side of the groove
for the phosphopantetheinyl arm by burying its side chain
in the hydrophobic core (as observed in TylKR1, one of the
rare B-type KRs that possess this tryptophan) (Figure 5B).
Polyketides are thus positioned by A- and C2-type KRs to
enter the active site from the left side.
The interaction of the lid helix with polyketide a-substit-
uents in A- and B-type KRs helps select the epimer that is
to be reduced. As revealed by the TylKR1 Q380L and
E424A mutants, the primary determinant of a-substituent
stereochemistry is the lid helix residue E424. In EryKR1,
a conserved valine from the lid helix is in a location to co-
operate with the leucine three residues before the catalytic
tyrosine in creating a hydrophobic pocket for the epimer-
ized methyl group. In general, the variability of the lid helix
prevents any strong fingerprints in this region from being
detected.
Epimerization
From the deuterium-labeling experiments, it is apparent
that the triketide formed by EryKS2 does not epimerize
appreciably [14], suggesting two possibilities: either spon-
taneous epimerization does not occur on the timescale of
polyketide production or the polyketide is shielded from
spontaneous epimerization. As polyketides are synthe-
sized by PKSs on the order of minutes and model diketideevier Ltd All rights reserved
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By combining the KR fingerprints, indicative of how a- and b-substituents are set, with how DH and ER can process intermediates, a protocol has
been developed to assign which of these ten ketide units will be added by a module. The first six are direct outcomes of the KR type present in
the module; the last four rely on the types of DH and ER present. The R groups can be determined by fingerprints in the accompanying AT domain
[29]. *, DH epimerase activity?substrates epimerize in water at least that quickly, the sec-
ond model is preferred [28]. As with fatty acid chains in an
FAS, polyketide chains may be sequestered inside the
ACP [27]. Within the ACP helical bundle, the unreduced
polyketide would be protected from bulk solvent and,
hence, spontaneous epimerization, as it is shuttled be-
tween the KS and KR active sites (Figure 4A).
That epimerizing KRs completely epimerize a polyketide
substrate seems to challenge the doctrine that enzymes
cannot alter the natural ratio between substrate and prod-
uct [18] (Figure 4B). However, an epimerizing KR is prob-
ably best defined as an enolase, so its reaction product
is actually an enol. Based on the available structures, the
most likely enolization mechanism is that a base abstracts
the polyketide a-hydrogen and the catalytic tyrosine do-
nates its hydrogen to the polyketide b-carbonyl oxygen.
The resulting enol can spontaneously tautomerize to the
lower-energy epimerized polyketide and be kinetically
trapped as such in the KR active site. The epimerized pol-
yketide may not be a substrate for enolization because its
a-hydrogen is inaccessible to the catalytic base.
In B2-type KRs, the putative epimerization mechanism
is that the tyrosine, freed from aF by a proline, acts as
the catalytic base, abstracting the acidic a-hydrogen
and donating its hydrogen to the b-carbonyl oxygen [18]
(Figure 4B). After a productive tautomerization, the epi-
merized polyketide is no longer a substrate for the epime-
rization reaction, as its a-hydrogen is on the other side of
the polyketide, inaccessible to the tyrosine. In A2- and
C2-type KRs, the reaction must be catalyzed differently,
as the unreduced, unepimerized polyketide enters the
active site from the left side. The a-hydrogen is most likely
abstracted by a lid helix residue or water molecule to
form the enol. The epimerized polyketide, formed when
the enol productively tautomerizes, is not a substrate
for enolization, as the base can no longer access the
a-hydrogen.Chemistry & Biology 14, 898Cryptic epimerization is not supported by current bio-
chemical and structural data to be a general mechanism
[15]. The deuterium-labeling experiments demonstrate
that the a-hydrogen is not lost from the polyketide as it
passes through EryMod2, indicating that the polyketide
is not in the enol form in the A1-type EryKR2. A polyketide
enol cannot be formed in the B1-type TylKR1, due to a ste-
ric clash that would result with E424. The mechanism is
also not sterically feasible in the B2-type EryKR1, as a hy-
dride and a proton would need to be added concurrently
from the same face of the polyketide at the b- and a-
carbons. The mechanism is only a formal possibility in
A2-type KRs, which possess a conserved histidine in the
necessary location to donate a proton to the a-carbon.
Several PKSs contain DHs that catalyze epimerization.
DHs may be more natural at this reaction than KRs, as
the first step in the dehydration mechanism is the abstrac-
tion of the a-proton. There are several examples: MyxDH2
performs epimerization prior to a reduction catalyzed by
an A-type KR; AscDH2, RifDH6, and RifDH7 perform epi-
merizations prior to a reduction catalyzed by a B-type KR;
and RapDH3 and RapDH6 perform epimerizations that are
not followed by reduction.
Protocol to Assign Substituent Chiralities
By combining the fingerprints indicative of how a- and b-
substituent chiralities are set by KRs with how DHs and
ERs can further process the resulting intermediates, a pro-
tocol has been generated to assign polyketide substituent
chirality based on the sequence of a module (Figure 6).
The first six possibilities are direct outcomes of the KR
type that acts on a polyketide in a given module (unless
an epimerizing DH is present). The next two outcomes de-
pend on both the KR type and the presence of an active
DH. In rare cases, such as RifMod10, a DH accompanies
an A1-type KR to produce a cis double bond [12]. The final
two outcomes depend on whether ER is ‘‘epimerizing’’–908, August 2007 ª2007 Elsevier Ltd All rights reserved 905
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More examples of ERs must be discovered for these fin-
gerprints to be proposed. To determine the identity of an
a-substituent, fingerprints in the accompanying AT can
be examined: an HAFH motif indicates that it selects a ma-
lonyl group so there is no a-substituent, whereas a YASH
motif indicates that it selects a methylmalonyl group so the
a-substituent is a methyl group. The fingerprints for other
AT selectivities are not as well defined, as there are fewer
examples of them [29].
The protocol presented here can be used to both verify
and derive polyketide structures. Small-molecule NMR
and crystallography do not always yield correct stereo-
chemical assignments, hence polyketide substituent chi-
ralities are often incompletely and even incorrectly anno-
tated [30, 31]. Dictyostatin is a 22-membered macrolide
that exhibits Taxol-like properties. Before attempting its
synthesis, chemists were wise to thoroughly examine its
reported structure—it was misassigned at seven chiral
centers [30, 32]. If the dictyostatin PKS sequence were
available to the chemists, the protocol would have pre-
sented an easier route to verifying the stereocenters.
The PKSs for many polyketides are available. By applying
the protocol to the recently reported structure of merida-
mycin using the associated PKS sequence, more than
half of the stereocenters appear to be misassigned
[33]. A careful examination of its structure should be
pursued. Although the protocol is not infallible, its utility
is undeniable.
Engineering Polyketide Synthases
The obvious route of engineering PKSs through swapping
KR domains has only yielded a few successes [34, 35].
This technique may suffer from the incompatability be-
tween the inserted KR and the native ACP. An alternative
approach, which does not disrupt domain interactions, is
to alter KR selectivity through site-directed mutagenesis
[13]. Recently, an EryKR1 mutant with a tryptophan engi-
neered into the left side of the groove was shown to exclu-
sively produce a reduced diketide with a b-hydroxyl group
of ‘‘S’’ stereochemistry. Thus, a B2-type KR was success-
fully converted into an A2-type KR. If such engineered KRs
are functional inside PKSs, then libraries of novel polyke-
tides can be generated through the combinatorial muta-
genesis of KRs within PKSs.
SIGNIFICANCE
In order to engineer PKSs that produce novel polyke-
tides ofmedicinal value, themechanisms of their com-
ponent enzymesmust be deciphered. The KR is a prin-
cipal target in PKS engineering, as it controls the
majority of polyketide stereocenters. By comparing
the structure of the tylosin KR reported here with a re-
cently solved erythromycin KR, residues involved in
polyketide binding, epimerization, and reduction, and
how they cooperate to control substituent stereo-
chemistries, were elucidated. The nomenclature for
KR types, which is currently only reflective of how906 Chemistry & Biology 14, 898–908, August 2007 ª2007 ElsKRs set the hydroxyl group stereochemistry, was ex-
panded to reflect how KRs also set the neighboring
acyl-substituent stereochemistry. A methodology
was created to deduce the identities and chiralities
of substituents added by a PKS module based on the
sequences of its component enzymes. Together,
these advances will give thrust to the development
of novel polyketide pharmaceuticals.
EXPERIMENTAL PROCEDURES
Cloning
DNA encoding the KR fragment was amplified from S. fradiae genomic
DNA with primers 50-GCAGATATACATATGAGCCCCACCGATGCCTG
GCGC-30 and 50-GTGGTGCTCGAGTCATCAGGCTGCCGTCAGGGC
CTCCCG-30, digested with NdeI and XhoI, and inserted into pET28b
between the NdeI and XhoI sites. To create the Q380L mutant, Quik-
Change (Stratagene) was performed with 50-GGCAACGCCGGCCTG
GGTGCGTACGCC-30 and 50-GGCGTACGCACCCAGGCCGGCGTT
GCC-30. To create the E424A mutant, QuikChange was performed
with 50-GGCGGGTGCGGGCGCGGAGAGTCTGTCGC-30 and 50-
GCGACAGACTCTCCGCGCCCGCACCCGCC-30.
Protein Expression, Purification, and Crystallization
For each protein, Escherichia coli BL21(DE3) cells were transformed
with the appropriate plasmid. The cells were grown in Luria broth at
37C to OD600 = 0.4, cooled to 15C, and induced with 1 mM IPTG. Af-
ter 14 hr, the cells were harvested, resuspended in lysis buffer (0.5 M
NaCl, 30 mM Tris [pH 7.4]), and lysed by sonication. After centrifuga-
tion, the lysate was poured over a nickel-NTA column equilibrated
with lysis buffer. The bound protein was washed with 15 mM imidazole
in lysis buffer and eluted with 150 mM imidazole in lysis buffer. The pro-
tein was passed through a Superdex 200 gel-filtration column equili-
brated with 150 mM NaCl, 10 mM Tris (pH 7.4) and concentrated to
10 mg/ml.
TylKR1 crystallized in 1.5 M ammonium sulfate, 0.1 M Tris (pH 8.0)
by hanging-drop vapor diffusion at 22C with a protein to crystalliza-
tion buffer ratio of 1:1. Crystals were cryoprotected in 20% glycerol,
1.8 M ammonium sulfate, 0.1 M Tris (pH 8.0) for 5 s prior to freezing
in liquid nitrogen. Cocrystallizing and soaking with NADPH and diketi-
des were attempted; however, no density from these substrates was
observed.
Data Processing and Refinement
Data collected at Advanced Light Source beamline 8.3.1 were pro-
cessed with HKL2000 [36] (Table 1). The EryKR1 structure (PDB ID
code 2FR0) was used as a search model for molecular replacement in
Phaser [37]. Several rounds of refinement in CNS and model building
in Coot were performed [38, 39]. Two large loops were not observable
in the electron density maps corresponding to 24 residues between b6
and a5 and 11 residues between b1 and b2.
Enzymatic Activity Assays
Enzymes were incubated with 5 mM NADPH and 0.5 mM diketide sub-
strate analog in 300 mM Na2PO4 (pH 8.0) at 22
C for 1 hr. Ethyl acetate
extracts of the reactions were analyzed by LC/MS with a C18 reverse-
phase column (20%–30% acetonitrile/water gradient).
Supplemental Data
Supplemental Data contain the synthesis of the diketide substrate with
NMR spectral data and one figure and are available at http://www.
chembiol.com/cgi/content/full/14/8/898/DC1/.evier Ltd All rights reserved
Chemistry & Biology
Ketoreductase Control of Polyketide StereocentersACKNOWLEDGMENTS
Ralph Reid, Chris Reeves, and Hugo Menzella shared their knowledge
of PKS enzymology. Robert Stroud and Janet Finer-Moore assisted in
interpreting experimental results. Research was supported by National
Cancer Institute, National Institutes of Health grant CA63081 (to Robert
Stroud).
Received: April 7, 2007
Revised: June 9, 2007
Accepted: July 9, 2007
Published: August 24, 2007
REFERENCES
1. Staunton, J., and Wilkinson, B. (1997). Biosynthesis of erythromy-
cin and rapamycin. Chem. Rev. 97, 2611–2630.
2. O’Hagan, D.O. (1991). The Polyketide Metabolites (Chichester,
UK: Ellis Horwood).
3. Staunton, J., and Weissman, K.J. (2001). Polyketide biosynthesis:
a millennium review. Nat. Prod. Rep. 18, 380–416.
4. Khosla, C., Tang, Y., Chen, A.Y., Schnarr, N.A., and Cane, D.E.
(2007). Structure and mechanism of the 6-deoxyerythronolide B
synthase. Annu. Rev. Biochem. 76, 195–221.























Bond lengths (A˚) 0.007
Bond angles () 1.1
Statistics in parentheses refer to the highest resolution shell
(1.95–2.02 A˚).Chemistry & Biology 14, 8985. Sherman, D.H., and Smith, J.L. (2006). Clearing the skies over
modular polyketide synthases. ACS Chem. Biol. 1, 505–509.
6. Cundliffe, E., Bate, N., Butler, A., Fish, S., Gandecha, A., and
Merson-Davies, L. (2001). The tylosin-biosynthetic genes ofStrep-
tomyces fradiae. Antonie Van Leeuwenhoek 79, 229–234.
7. Tang, Y., Kim, C.Y., Mathews, I.I., Cane, D.E., and Khosla, C.
(2006). The 2.7-A˚ crystal structure of a 194-kDa homodimeric frag-
ment of the 6-deoxyerythronolide B synthase. Proc. Natl. Acad.
Sci. USA 103, 11124–11129.
8. Smith, S., Witkowski, A., and Joshi, A.K. (2003). Structural and
functional organization of the animal fatty acid synthase. Prog.
Lipid Res. 42, 289–317.
9. Maier, T., Jenni, S., and Ban, N. (2006). Architecture of mammalian
fatty acid synthase at 4.5 A˚ resolution. Science 311, 1258–1262.
10. Donadio, S., and Katz, L. (1992). Organization of the enzymatic
domains in the multifunctional polyketide synthase involved in
erythromycin formation in Saccharopolyspora erythraea. Gene
111, 51–60.
11. Caffrey, P. (2005). The stereochemistry of ketoreduction. Chem.
Biol. 12, 1060–1062.
12. Reid, R., Piagentini, M., Rodriguez, E., Ashley, G., Viswanathan,
N., Carney, J., Santi, D.V., Hutchinson, C.R., and McDaniel, R.
(2003). A model of structure and catalysis for ketoreductase do-
mains in modular polyketide synthases. Biochemistry 42, 72–79.
13. Baerga-Ortiz, A., Popovic, B., Siskos, A.P., O’Hare, H.M., Spiteller,
D., Williams, M.G., Campillo, N., Spencer, J.B., and Leadlay, P.F.
(2006). Directed mutagenesis alters the stereochemistry of cataly-
sis by isolated ketoreductase domains from the erythromycin
polyketide synthase. Chem. Biol. 13, 277–285.
14. Weissman, K.J., Timoney, M., Bycroft, M., Grice, P., Hanefeld, U.,
Staunton, J., and Leadlay, P.F. (1997). The molecular basis of
Celmer’s rules: the stereochemistry of the condensation step in
chain extension on the erythromycin polyketide synthase.
Biochemistry 36, 13849–13855.
15. Starcevic, A., Jaspars, M., Cullum, J., Hranueli, D., and Long, P.F.
(2007). Predicting the nature and timing of epimerisation on a mod-
ular polyketide synthase. ChemBioChem 8, 28–31.
16. Cane, D.E., Liang, T.C., Taylor, P.B., Chang, C., and Yang, C.C.
(1986). Macrolide biosynthesis. 3. Stereochemistry of the chain-
elongation steps of erythromycin biosynthesis. J. Am. Chem.
Soc. 108, 4957–4964.
17. Holzbaur, I.E., Ranganathan, A., Thomas, I.P., Kearney, D.J.,
Reather, J.A., Rudd, B.A., Staunton, J., and Leadlay, P.F. (2001).
Molecular basis of Celmer’s rules: role of the ketosynthase domain
in epimerisation and demonstration that ketoreductase domains
can have altered product specificity with unnatural substrates.
Chem. Biol. 8, 329–340.
18. Keatinge-Clay, A.T., and Stroud, R.M. (2006). The structure of a -
ketoreductase determines the organization of the b-carbon pro-
cessing enzymes of modular polyketide synthases. Structure 14,
737–748.
19. Siskos, A.P., Baerga-Ortiz, A., Bali, S., Stein, V., Mamdani, H.,
Spiteller, D., Popovic, B., Spencer, J.B., Staunton, J., Weissman,
K.J., and Leadlay, P.F. (2005). Molecular basis of Celmer’s rules:
stereochemistry of catalysis by isolated ketoreductase domains
from modular polyketide synthases. Chem. Biol. 12, 1145–1153.
20. Burdett, G.L., and Rogers, M.T. (1964). Keto-enol tautomerism in
b-dicarbonyls studied by nuclear magnetic resonance spectros-
copy 1. Proton chemical shifts and equilibrium constants of pure
compounds. J. Am. Chem. Soc. 86, 2105–2109.
21. Fisher, M., Kroon, J.T., Martindale, W., Stuitje, A.R., Slabas, A.R.,
and Rafferty, J.B. (2000). The X-ray structure of Brassica napus b-
keto acyl carrier protein reductase and its implications for sub-
strate binding and catalysis. Structure 8, 339–347.–908, August 2007 ª2007 Elsevier Ltd All rights reserved 907
Chemistry & Biology
Ketoreductase Control of Polyketide Stereocenters22. Oppermann, U., Filling, C., Hult, M., Shafqat, N., Wu, X., Lindh, M.,
Shafqat, J., Nordling, E., Kallberg, Y., Persson, B., and Jornvall, H.
(2003). Short-chain dehydrogenases/reductases (SDR): the 2002
update. Chem. Biol. Interact. 143–144, 247–253.
23. Yamashita, A., Endo, M., Higashi, T., Nakatsu, T., Yamada, Y.,
Oda, J., and Kato, H. (2003). Capturing enzyme structure prior to
reaction initiation: tropinone reductase-II-substrate complexes.
Biochemistry 42, 5566–5573.
24. Rozwarski, D.A., Vilcheze, C., Sugantino, M., Bittman, R., and
Sacchettini, J.C. (1999). Crystal structure of the Mycobacterium
tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+
and a C16 fatty acyl substrate. J. Biol. Chem. 274, 15582–15589.
25. Zhang, Y.M., Rao, M.S., Heath, R.J., Price, A.C., Olson, A.J., Rock,
C.O., and White, S.W. (2001). Identification and analysis of the acyl
carrier protein (ACP) docking site on b-ketoacyl-ACP synthase III.
J. Biol. Chem. 276, 8231–8238.
26. Zhang, Y.M., Wu, B., Zheng, J., and Rock, C.O. (2003). Key resi-
dues responsible for acyl carrier protein and b-ketoacyl-acyl car-
rier protein reductase (FabG) interaction. J. Biol. Chem. 278,
52935–52943.
27. Roujeinikova, A., Simon, W.J., Gilroy, J., Rice, D.W., Rafferty, J.B.,
and Slabas, A.R. (2007). Structural studies of fatty acyl-(acyl car-
rier protein) thioesters reveal a hydrophobic binding cavity that
can expand to fit longer substrates. J. Mol. Biol. 365, 135–145.
28. Holzbaur, I.E., Harris, R.C., Bycroft, M., Cortes, J., Bisang, C.,
Staunton, J., Rudd, B.A., and Leadlay, P.F. (1999). Molecular basis
of Celmer’s rules: the role of two ketoreductase domains in the
control of chirality by the erythromycin modular polyketide
synthase. Chem. Biol. 6, 189–195.
29. Yadav, G., Gokhale, R.S., and Mohanty, D. (2003). Computational
approach for prediction of domain organization and substrate
specificity of modular polyketide synthases. J. Mol. Biol. 328,
335–363.
30. Nicolaou, K.C., and Snyder, S.A. (2005). Chasing molecules that
were never there: misassigned natural products and the role of
chemical synthesis in modern structure elucidation. Angew.
Chem. Int. Ed. Engl. 44, 1012–1044.
31. Kitamura, M., Nakano, K., Miki, T., Okada, M., and Noyori, R.
(2001). Stereochemistry of aldols: configuration and conformation908 Chemistry & Biology 14, 898–908, August 2007 ª2007 Elseof aldols derived from cycloalkanones and aldehydes. J. Am.
Chem. Soc. 123, 8939–8950.
32. Paterson, I., Britton, R., Delgado, O., and Wright, A.E. (2004).
Stereochemical determination of dictyostatin, a novel microtu-
bule-stabilising macrolide from the marine sponge Corallistidae
sp. Chem. Commun. (Camb.) (6), 632–633.
33. Sun, Y., Hong, H., Samborskyy, M., Mironenko, T., Leadlay, P.F.,
and Haydock, S.F. (2006). Organization of the biosynthetic gene
cluster in Streptomyces sp. DSM 4137 for the novel neuroprotec-
tant polyketide meridamycin. Microbiology 152, 3507–3515.
34. Kao, C.M., McPherson, M., McDaniel, R.N., Fu, H., Cane, D.E.,
and Khosla, C. (1998). Alcohol stereochemistry in polyketide back-
bones is controlled by the b-ketoreductase domains of modular
polyketide synthases. J. Am. Chem. Soc. 120, 2478–2479.
35. McDaniel, R., Thamchaipenet, A., Gustafsson, C., Fu, H., Betlach,
M., and Ashley, G. (1999). Multiple genetic modifications of the
erythromycin polyketide synthase to produce a library of novel
‘‘unnatural’’ natural products. Proc. Natl. Acad. Sci. USA 96,
1846–1851.
36. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffrac-
tion data collected in oscillation mode. In Methods in Enzymology,
Volume 276: Macromolecular Crystallography, Part A, C.W.
Carter, Jr. and R.M. Sweet, eds. (New York: Academic Press),
pp. 307–326.
37. CCP4 (Collaborative Computational Project, Number 4) (1994).
The CCP4 suite: programs for protein crystallography. Acta
Crystallogr. D Biol. Crystallogr. 50, 760–763.
38. Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M.,
Pannu, N.S., et al. (1998). Crystallography & NMR System: a new
software suite for macromolecular structure determination. Acta
Crystallogr. D Biol. Crystallogr. 54, 905–921.
39. Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for
molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–
2132.
Accession Numbers
The atomic coordinates of TylKR1 have been deposited in the Protein
Data Bank under ID code 2Z5L.vier Ltd All rights reserved
